The circadian system and the therapeutics of the affective disorders - PubMed (original) (raw)
Review
The circadian system and the therapeutics of the affective disorders
D Healy et al. Pharmacol Ther. 1995 Feb.
Abstract
Establishing that a circadian rhythm is abnormal tells us little about the cause, which can arise from changes in the patient's lifestyle, irregularities of the body clock or a malfunction in the process of entrainment of the clock. In a clinical context, such a range of possible explanations implies differences in the most appropriate mode of treatment. Against this background, the conventional view that the underlying abnormality in endogenous depression is due to a disorder of the body clock is challenged. The challenge is based on difficulties of interpretation of the clinical data and the results of studies on circadian rhythms in patients. It is suggested that the state of the circadian system in depression resembles its state in healthy individuals after time-zone transitions or in shift work maladaptation syndrome and that this disturbance should be seen as resulting from changes in the phasing of external zeitgebers rather than from an abnormality in the clock itself.
Similar articles
- Chronobiology of bipolar disorder: therapeutic implication.
Dallaspezia S, Benedetti F. Dallaspezia S, et al. Curr Psychiatry Rep. 2015 Aug;17(8):606. doi: 10.1007/s11920-015-0606-9. Curr Psychiatry Rep. 2015. PMID: 26112914 Review. - Melatonin in mood disorders.
Srinivasan V, Smits M, Spence W, Lowe AD, Kayumov L, Pandi-Perumal SR, Parry B, Cardinali DP. Srinivasan V, et al. World J Biol Psychiatry. 2006;7(3):138-51. doi: 10.1080/15622970600571822. World J Biol Psychiatry. 2006. PMID: 16861139 Review. - Circadian genes, rhythms and the biology of mood disorders.
McClung CA. McClung CA. Pharmacol Ther. 2007 May;114(2):222-32. doi: 10.1016/j.pharmthera.2007.02.003. Epub 2007 Feb 28. Pharmacol Ther. 2007. PMID: 17395264 Free PMC article. Review. - Circadian rhythms and depression.
Boyce P, Barriball E. Boyce P, et al. Aust Fam Physician. 2010 May;39(5):307-10. Aust Fam Physician. 2010. PMID: 20485718 Review.
Cited by
- Lithium therapy and hyperparathyroidism: an evidence-based assessment.
Saunders BD, Saunders EF, Gauger PG. Saunders BD, et al. World J Surg. 2009 Nov;33(11):2314-23. doi: 10.1007/s00268-009-9942-4. World J Surg. 2009. PMID: 19252941 Review. - Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.
Gannon RL, Millan MJ. Gannon RL, et al. Psychopharmacology (Berl). 2007 Dec;195(3):325-32. doi: 10.1007/s00213-007-0903-z. Epub 2007 Aug 13. Psychopharmacology (Berl). 2007. PMID: 17694388 - Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway.
Zhu H, Bogdanov MB, Boyle SH, Matson W, Sharma S, Matson S, Churchill E, Fiehn O, Rush JA, Krishnan RR, Pickering E, Delnomdedieu M, Kaddurah-Daouk R; Pharmacometabolomics Research Network. Zhu H, et al. PLoS One. 2013 Jul 17;8(7):e68283. doi: 10.1371/journal.pone.0068283. Print 2013. PLoS One. 2013. PMID: 23874572 Free PMC article. Clinical Trial. - Brief constant light accelerates serotonergic re-entrainment to large shifts of the daily light/dark cycle.
Kaur G, Thind R, Glass JD. Kaur G, et al. Neuroscience. 2009 Apr 10;159(4):1430-40. doi: 10.1016/j.neuroscience.2009.02.016. Epub 2009 Feb 13. Neuroscience. 2009. PMID: 19217929 Free PMC article. - The behavioral actions of lithium in rodent models: leads to develop novel therapeutics.
O'Donnell KC, Gould TD. O'Donnell KC, et al. Neurosci Biobehav Rev. 2007;31(6):932-62. doi: 10.1016/j.neubiorev.2007.04.002. Epub 2007 Apr 13. Neurosci Biobehav Rev. 2007. PMID: 17532044 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical